Tuesday, January 26, 2021

inhalers

FDA Objects To Sale And Marketing Of Nasal, Ophthalmic, Inhalable CBD Products

This latest round of enforcement actions was triggered by specific concerns with the manner in which many CBD products were administered.

FOR A WEEKLY DOSE OF THE FRESH TOAST

Hand selected from our editors with all the latest news and entertainment with a side of cannabis.

Follow Us

123,000FansLike
7,000FollowersFollow
6,500FollowersFollow

Latest Articles